Document is current
Any future updates will be listed below
-
Authors
Mallardo, Domenico
Woodford, Rachel
Menzies, Alexander M.
Zimmer, Lisa
williamson, Andrew
Ramelyte, Egle
Dimitriou, Florentia
Wicky, Alexandre
Wallace, Roslyn
Mallardo, Mario
Cortellini, Alessio
Budillon, Alfredo
Atkinson, Victoria
Sandhu, Shahneen
Olivier, Michielin
Dummer, Reinhard
Lorigan, Paul
Schadendorf, Dirk
Long, Georgina V.
Simeone, Ester
Ascierto, Paolo A. https://orcid.org/0000-0002-8322-475X
- License Information
-
More Information
Article History
Received: 6 October 2023
Accepted: 8 October 2023
First Online: 25 October 2023
Declarations
:
: The study was performed in accordance with the revised version of the Declaration of Helsinki (52nd WMA General Assembly, Edinburgh, Scotland, October 2000). All patients released informed consent to participate.
: All patients consented to the publication of anonymous data.
: PAA has/had a consultant/advisory role for Bristol Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Merck Serono, Pierre-Fabre, AstraZeneca, Sun Pharma, Sanofi, Idera, Sandoz, Immunocore, 4SC, Italfarmaco, Nektar, Boehringer-Ingelheim, Eisai, Regeneron, Daiichi Sankyo, Pfizer, Oncosec, Nouscom, Lunaphore, Seagen, iTeos, Medicenna, Bio-Al Health. He also received research funding from Bristol Myers Squibb, Roche-Genentech, Pfizer, Sanofi. AC received grant consultancies from BMS, MSD, OncoC4, IQVIA, Roche, GSK, AstraZeneca, Access Infinity, Ardelis Health. He also received speaker's fee from Astrazeneca, Novartis, Pierre-Fabre, Eisai. AMM has served on advisory boards for BMS, MSD, Novartis, Roche, Pierre-Fabre and QBiotics.
